RHYTHM PHARMACEUTICALS, INC. — Form 4
Filed September 14, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 54/100
What the filing says
President and CEO Meeker David P (RYTM) sold 100K shares (~$5.1M) on the open market (87% of holdings). Large sale — ~87% of holdings.
Why this rating
Large sale — ~87% of holdings.
See more from September 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.